Literature DB >> 7332882

Yersinia enterocolitica isolated from throats of swine in eastern and western Canada.

D A Schiemann, C A Fleming.   

Abstract

Examination of the throat flora from swine in Ontario for Yersinia enterocolitica found the incidence of serotype O:3 to vary from 20% from tonsils to 50% for throat swabs and 55% for tongues. In contrast, there were no isolations of serotype O:3 from throat swabs taken from swine in the western provinces of British Columbia and Alberta. This incidence of serotype O:3 in swine correlates well with the human incidence of the same serotype which is 81% for all human isolations of Y. enterocolitica in the eastern provinces and 4% in the western provinces of Canada. The opposite relationship is true for serotype O:5,27, which was not isolated from Ontario swine but occurred with a frequency of 3% in British Columbia swine and 24% in Alberta swine. The relative incidence in humans for serotype O:5,27 is 5% of all isolations of Y. enterocolitica in Ontario, 8% in British Columba, and 26% in Alberta. Serotype O:8, the most common human serotype in the western provinces (40% of all isolations), was not isolated from swine in this survey. The majority of Y. enterocolitica cultures of biotype 4 (serotype O:3) and biotype 2 (serotype O:5,27) were positive for autoagglutination, a test which has been associated with virulence, whereas all cultures of biotype 1 were negative. The results from this study strongly suggest that swine are an important source of human infections with both serotype O:3 and O:5,27 of Y. enterocolitica. The source of human infections in western Canada with serotype O:8 remains unidentified.

Entities:  

Mesh:

Year:  1981        PMID: 7332882     DOI: 10.1139/m81-203

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  11 in total

1.  The pathogenicity of Yersinia enterocolitica for piglets.

Authors:  D A Schiemann
Journal:  Can J Vet Res       Date:  1988-07       Impact factor: 1.310

2.  Comparison of sampling and isolation procedures for recovery of Yersinia enterocolitica serotype O:3 from the oral cavity of slaughter pigs.

Authors:  T Nesbakken
Journal:  Acta Vet Scand       Date:  1985       Impact factor: 1.695

3.  The prevalence of Yersinia enterocolitica 0:3 in Finnish pigs and pork.

Authors:  K Asplund; V Tuovinen; P Veijalainen; J Hirn
Journal:  Acta Vet Scand       Date:  1990       Impact factor: 1.695

4.  Recovery of Yersinia enterocolitica from patients with gastrointestinal disturbances. Lack of efficacy of alkali method.

Authors:  G Marinelli; C Chiesa; M Pupi; E Tomei
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

5.  Epidemiological study of Yersinia enterocolitica in swine herds in Québec.

Authors:  J Pilon; R Higgins; S Quessy
Journal:  Can Vet J       Date:  2000-05       Impact factor: 1.008

6.  Bacteria of pathogenic importance in faeces from cadavers of free-ranging or corralled semi-domesticated reindeer in northern Norway.

Authors:  A Aschfalk; N Kemper; C Höller
Journal:  Vet Res Commun       Date:  2003-02       Impact factor: 2.459

7.  Transfer of the core region genes of the Yersinia enterocolitica WA-C serotype O:8 high-pathogenicity island to Y. enterocolitica MRS40, a strain with low levels of pathogenicity, confers a yersiniabactin biosynthesis phenotype and enhanced mouse virulence.

Authors:  Cosima Pelludat; Michael Hogardt; Jürgen Heesemann
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

8.  Clinical significance of virulence-related assay of Yersinia species.

Authors:  M A Noble; R L Barteluk; H J Freeman; R Subramaniam; J B Hudson
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

9.  Clonal diversity and relationships among strains of Yersinia enterocolitica.

Authors:  D A Caugant; S Aleksic; H H Mollaret; R K Selander; G Kapperud
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

10.  Growth of Yersinia pseudotuberculosis and Yersinia enterocolitica biotype 3B serotype O3 inhibited on cefsulodin-Irgasan-novobiocin agar.

Authors:  H Fukushima; M Gomyoda
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.